Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Northern Care AllianceNHS Foundation Trust, Salford, UK.
Division of Psychology, Communication & Human Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
J Neurol. 2024 Dec;271(12):7471-7488. doi: 10.1007/s00415-024-12706-5. Epub 2024 Oct 10.
Apraxia has been identified in all clinical forms of frontotemporal lobar degeneration (FTLD). The characteristics of apraxia symptoms and their underlying cognitive/motor basis are not fully understood. This study investigated apraxia in pathological subtypes of FTLD.
The study constituted a retrospective review of 115 pathologically confirmed cases of FTLD from a single cognitive neurology centre. Patients in whom apraxia had been documented as a notable clinical characteristic were identified. Apraxia features, demographic, cognitive, neurological, and imaging findings were recorded.
Eighteen patients were identified: 12 with FTLD-tau pathology (7 corticobasal degeneration (CBD), four Pick type and one progressive supranuclear palsy (PSP)) and six with FTLD-TDP pathology, all type A and four linked to progranulin gene mutations. Apraxia as a dominant presenting feature was typically associated with tau pathologies, whereas it emerged in the context of aphasia in TDP pathology. Apraxia typically predominated in one body part (face or limb) in tau but not TDP pathology. Relatively preserved activities in daily life were associated with TDP. Apraxia of speech was associated with tau pathology. Pick-type pathology was linked to symmetrical atrophy and late development of limb rigidity.
Apraxia in FTLD subtypes has variable characteristics. Apraxia associated with CBD pathology conformed to criteria for probable corticobasal syndrome (CBS), whereas apraxia with Pick-type pathology did not. Apraxia in patients with TDP-A pathology was interpreted as one manifestation of their generalised communication disorder. Apraxia in FTLD may have distinct cognitive and motor substrates that require prospective investigation.
失用症已在额颞叶变性(FTLD)的所有临床形式中被确定。失用症症状的特征及其潜在的认知/运动基础尚不完全清楚。本研究调查了 FTLD 病理亚型中的失用症。
本研究对来自单一认知神经病学中心的 115 例经病理证实的 FTLD 病例进行了回顾性分析。确定了将失用症记录为显著临床特征的患者。记录了失用症特征、人口统计学、认知、神经学和影像学发现。
确定了 18 名患者:12 名患有 FTLD-tau 病理学(7 名皮质基底节变性(CBD),4 名 Pick 型和 1 名进行性核上性麻痹(PSP))和 6 名患有 FTLD-TDP 病理学,均为 A 型,其中 4 名与颗粒蛋白基因突变有关。作为主要表现特征的失用症通常与 tau 病理学有关,而在 TDP 病理学中则出现在失语症的背景下。失用症通常在 tau 病理学中占主导地位的身体部位(面部或肢体),而在 TDP 病理学中则不然。相对保留的日常生活活动与 TDP 相关。言语失用症与 tau 病理学有关。Pick 型病理学与对称萎缩和肢体僵硬的后期发展有关。
FTLD 亚型中的失用症具有不同的特征。与 CBD 病理学相关的失用症符合可能的皮质基底节综合征(CBS)的标准,而与 Pick 型病理学相关的失用症则不符合。TDP-A 病理学患者的失用症被解释为其一般交流障碍的一种表现。FTLD 中的失用症可能具有不同的认知和运动基础,需要前瞻性研究。